You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2026

AbstractFullPdf
Nov 202018618669
Dec 2020439439202
Jan 202120120183
Feb 202116216272
Mar 202119719763
Apr 202117617696
May 202114514573
Jun 202111411454
Jul 2021777751
Aug 2021717135
Sep 2021979759
Oct 202115415451
Nov 2021848359
Dec 2021899149
Jan 2022738427
Feb 2022646535
Mar 202211913850
Apr 202216918749
May 202212212844
Jun 202212312935
Jul 202212012223
Aug 202212712938
Sep 202211912333
Oct 202212813041
Nov 202211912141
Dec 202210810922
Jan 2023747625
Feb 202311712030
Mar 202311812150
Apr 2023686837
May 2023919230
Jun 2023808121
Jul 2023636324
Aug 2023878813
Sep 2023949523
Oct 2023909223
Nov 2023767622
Dec 2023767723
Jan 2024434424
Feb 202410310423
Mar 2024858738
Apr 2024105107102
May 2024818342
Jun 2024919121
Jul 202410010138
Aug 2024696932
Sep 2024595926
Oct 2024858936
Nov 2024768439
Dec 2024868750
Jan 202510010035
Feb 2025676940
Mar 2025707036
Apr 202512612626
May 2025636341
Jun 2025535332
Dec 2025110
Mar 2026110
Total608161952456